Company / Inventory
Tvardi Therapeutics, Inc. Inventory History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$900.0K
FY2024
5-year range
$900.0K / $2.8M
FY2021-FY2024
Trend
-68.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $900,000 over the past 2 years.
Based on SEC 10-K filings.
$900,000 in FY2024 with a 3-year CAGR of -29.6%.
Declined from $2M to $900,000 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -29.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -29.6%, indicating a declining trend.
- In FY2024, inventory decreased 68.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $900.0K | -68.1% |
| FY2023 | $2.8M | +18.4% |
| FY2022 | $2.4M | -7.8% |
| FY2021 | $2.6M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026